home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Stem Cell Fusion Repairs Damaged Liver

  March, 31 2003 9:19
your information resource in human molecular genetics
Transplanted stem cells may repair liver damage by fusing with host cells, report two papers published online by Nature this week. These findings will fuel the ongoing debate over stem cell versatility and the mechanisms by which the cells repair tissues.

Previous research has suggested that transplants of stem cells from bone marrow can cure mice of a fatal metabolic liver disease, apparently by generating new liver cells. Markus Grompe and colleagues from the Oregon Health and Science University, Portland, now find that these 'new' liver cells actually contain a mix of genes from the transplanted stem cells and the recipient mouse, and that some cells contain double or triple sets of chromosomes.

David Russell and colleagues from the University of Washington, Seattle, also find evidence for fusion, after stem cells from bone marrow are transplanted into mice with tyrosinaemia, another liver disorder. The hybrid cells have a liver-like pattern of gene expression.

Both groups conclude that, at least in the liver, transplanted stem cells can fuse with host cells, and may be reprogrammed into functioning tissue cells.

Author contacts:

Markus Grompe
Dept of Molecular & Medical Genetics
Oregon Health & Science University
Portland, OR
Tel: +1 503 494 6888
E-mail grompem@ohsu.edu
[Out of town from March 29 – April 4.
Please contact co-author Holger Willenbring (+1 503 494 6889; willenbr@ohsu.edu) during this time.]

David Russell
Division of Hematology
University of Washington
Seattle, WA
Tel: +1 206 616 4562
E-mail: drussell@u.washington.edu

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.